RecruitingNot Applicable

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

United States30 participantsStarted 2025-12-17

Plain-language summary

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Open-angle glaucoma * 18 years of age or older Exclusion Criteria: * Subject who is breast-feeding or pregnant

What they're measuring

Successful implantation

Timeframe: 1 day

Trial details

NCT IDNCT07400926

SponsorGlaukos Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Study Director

949-739-8749 ClinicalResearch@glaukos.com

View on ClinicalTrials.gov More Open Angle Glaucoma (OAG) trials